LABGENOMICS is involved in the development of next-generation sequencing (NGS) and siRNA therapeutics based on a novel nanoparticle drug delivery system.
LABGENOMICS
Category:
Diagnostics
Main Business Area
Next-generation sequencing (NGS) and siRNA therapeutics
Contact Details | 700 Daewangpangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do (Sampyeong-dong, Korea Biopark Building B, 6th floor)TEL.031-628-0702 |
---|
Find out more companies
Related products
-
Diagnostics
EYEGENE lnc. LTD
EYEGENE Inc. is a clinical-stage biopharmaceutical company developing vaccines and new innovative recombinant protein drugs.